Table 1.
Routine Timor-Leste vaccination schedule in 2022 and estimated coverage in 2018
| Vaccine | Recommended age of administration | Introduced | Crude estimated coverage (2018 national vaccine coverage survey) (95% CI)* (%) | Valid estimated coverage (2018 national vaccine coverage survey) (95% CI)† (%) |
| BCG | At birth | Pre-1999 | 94.7 (91.7–97.0) | 68.8 (61.3–75.0) |
| HepB0 | 2016 | 66.2 (58.5–73.0) | 55.0 (46.9–63.0) | |
| bOPV0 | 2016 | 80.4 (74.0–86.0) | 60.8 (52.2–69.0) | |
| DTwP‐Hib‐HepB1 | 6 weeks | 2007 | 91.8 (87.8–95.0) | 74.6 (68.4–80.0) |
| bOPV1 | 2016 | 91.8 (87.8–95.0) | 75.5 (69.4–81.0) | |
| RV1 | 2019 | Not part of routine vaccination in 2018 | ||
| DTwP‐Hib‐HepB2 | 10 weeks | 2007 | 87.4 (82.6–91.0) | 72.8 (66.7–78.0) |
| bOPV2 | 2016 | 87.8 (83.0–91.0) | 73.2 (66.9–79.0) | |
| RV2 | 2019 | Not part of routine vaccination in 2018 | ||
| DTwP‐Hib‐HepB3 | 14 weeks | 2007 | 83.3 (78.0–87.0) | 75.0 (68.8–80.0) |
| bOPV3 | 2016 | 83.3 (78.0–87.0) | 75.3 (69.0–81.0) | |
| RV3 | 2019 | Not part of routine vaccination in 2018 | ||
| IPV | 2016 | 80.6 (74.1–86.0) | 71.5 (64.6–77.0) | |
| MR1 | 9 months | 2016 | 77.3 (71.5–82.0) | 60.5 (54.0–67.0) |
| DTwP4 | 18 months | 2016 | 54.8 (46.5–63.0) | 16.0 (12.1–21.0) |
| MR2 | 2016 | 54.4 (46.1–62.0) | 12.5 (9.0–17.0) | |
| DT | 6 years or school entry | 2016 | Not measured in 2018 survey | |
| TT1-5 | Unimmunised pregnant women | Pre-1999 | 68.2 (62.4–74.0) | |
| SARS-CoV-2 | Adults and children above 12 years of age | Adults: April 2021 Children: October 2021 |
Not part of routine vaccination in 2018 |
*Crude coverage is defined as all doses, whether valid or not, by any documented evidence or verbal history at the time of the survey.
†Valid coverage includes only the doses of vaccines that were given on or after the minimum date of eligibility and requires a vaccination record (either home based or health facility) with a documented date.
BCG, BCG Calmette-Guérin; bOPV0, bivalent oral polio vaccine; DT, diphtheria and tetanus vaccine; DTwP‐Hib‐HepB, diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type B; HepB, hepatitis B; IPV, inactivated poliovirus vaccine; MR, measles and rubella vaccine; RV, rotavirus vaccine; TT, tetanus toxoid vaccine.